Asston Pharmaceuticals IPO is a book build IPO listing on BSE SME exchange. The company is based in Mumbai and caters to Pharmaceutical sector. Sobhagya Capital Options is the merchant banker of Asston Pharmaceuticals IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th January 2025.
Asston Pharmaceuticals IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Asston Pharmaceuticals IPO size is Rs [●] crores with IPO price of Rs [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Sobhagya Capital Options Limited is the book-running lead manager of the Asston Pharmaceuticals IPO. Maashitla Securities Private Limited is the Registrar and Market Maker is [●] for Asston Pharmaceuticals IPO.
Asston Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Asston Pharmaceuticals IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on . The company is launching its SME UPCOMING IPO on the BSE SME exchange, using the Book Building Issue method. Asston Pharmaceuticals IPO size is ₹ [●] Crores with fresh issue size of Rs [●] Crores and Offer for sale being Nil.
The IPO allotment date for Asston Pharmaceuticals IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Asston Pharmaceuticals IPO allotment status on the registrars website, Maashitla Securities Private Limited. Asston Pharmaceuticals IPO refund dates are [●].
Asston Pharmaceuticals IPO is expected to be listed on [●].
The upper price band for the Asston Pharmaceuticals IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Asston Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Asston Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Asston Pharmaceuticals IPO is finalised.
The merchant banker for Asston Pharmaceuticals IPO is Sobhagya Capital Options Limited . Sobhagya Capital Options Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Asston Pharmaceuticals IPO RHP for further details.
The registrar for Asston Pharmaceuticals IPO is Maashitla Securities Private Limited. Investors can go to Maashitla Securities Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Asston Pharmaceuticals IPO through their official website or helpline.
Asston Pharmaceuticals IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Asston Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Asston Pharmaceuticals Financial Review Page
Merchant Banker(s) of Asston Pharmaceuticals IPO: Sobhagya Capital Options Limited
Asston Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Asston Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Asston Pharmaceuticals is .
Why Us?